A national risk model that gauges a woman's chance of developing breast cancer has been refined to give a more accurate assessment. The revised figures, based on data from more than one million patients, reveal a 300 percent ...
Aug 19, 2015
0
21
Women who are diagnosed with ductal carcinoma in situ (DCIS) outside the NHS breast screening program are around four times as likely to develop invasive breast cancer and to die from breast cancer than women in the general ...
Jan 24, 2024
0
7
A receptor protein suppresses local invasion and metastasis of breast cancer cells, the most lethal aspect of the disease, according to a research team headed by scientists from The University of Texas MD Anderson Cancer ...
Sep 25, 2012
0
0
(HealthDay)—For women with early-stage, hormone receptor-positive invasive breast cancer, initiation of cholesterol-lowering medication (CLM) during endocrine therapy is associated with improved survival and distant recurrence-free ...
Feb 15, 2017
0
10
There is a relative increase of 20% to 30% in breast cancer risk associated with both combined and progestogen-only contraceptives, whatever the mode of delivery, though with five years of use, the 15-year absolute excess ...
Mar 21, 2023
0
50
Women who have gone through menopause and who have been using a vaginal form of estrogen therapy do not have a higher risk of cardiovascular disease and cancer than women who have not been using any type of estrogen.
Aug 16, 2017
0
2
Women who have inherited mutations in the BRCA1 or BRCA2 genes are more likely to develop breast cancer or ovarian cancer, especially at a younger age. Approximately 5 percent of women with breast cancer in the United States ...
Aug 25, 2015
0
40
Women who use the oestrogen-only form of hormone replacement therapy (HRT) appear less likely to develop breast cancer in the longer term, according to new research published Online First in The Lancet Oncology. A follow-up ...
Mar 6, 2012
0
0
Three major national databases include varying estimates of racial gaps in the use of immediate breast reconstruction (IBR) after mastectomy for breast cancer, reports a study in the March issue of Plastic and Reconstructive ...
Mar 30, 2017
0
1
(HealthDay) -- For women without diabetes and with operable breast cancer, administration of metformin prior to surgery does not significantly affect the proliferative marker Ki-67 overall, but drug effects are observed according ...
May 9, 2012
0
0
